Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Flavoxine
- Development stage
- Unknown
- Lead developer
- Next Pharmaceuticals
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Flavoxine is a patented, natural dietary supplement ingredient developed by Next Pharmaceuticals designed to support cardiovascular health. It is a proprietary combination of two botanical extracts: a proprietary extract of *Phellodendron amurense* bark and a patented extract of *Citrus sinensis* (orange) peel standardized for polymethoxylated flavones (PMFs). Clinical research indicates that Flavoxine significantly improves lipid profiles by reducing LDL-cholesterol and triglycerides while increasing HDL-cholesterol. Furthermore, it has demonstrated the ability to lower blood pressure, fasting blood glucose, and C-reactive protein (CRP), a key marker of systemic inflammation. It is marketed as a nutraceutical ingredient for inclusion in heart health formulations rather than as a prescription pharmaceutical drug.
- Brand names
- Flavoxine
- Other names
- Phellodendron amurense and Citrus sinensis extract
02
Targets
mAChR (Muscarinic acetylcholine receptors)
Beyond the preview
Go deeper on Flavoxine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Flavoxine.